Transdermal Clonidine in Chronic Hemodialysis Patients
Status:
Unknown status
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The majority of chronic hemodialysis patients need a combination of several antihypertensive
drugs for adequate BP control. The primary objective of this study is to evaluate whether
transdermal clonidine can improve blood pressure control or decrease oral antihypertensive
agents type or dosage and the secondary objective is to observe incidence of adverse
reactions of transdermal clonidine in chronic hemodialysis patients.